Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Daniel D Degnan"'
Publikováno v:
Patient Safety, Vol 6, Iss 1 (2024)
Neuromuscular blocking agents (NMBAs) are high-alert medications that require special handling, necessitating a robust process that prevents medication error, identifies near misses, and ultimately protects patients from harm. One patient at a large
Externí odkaz:
https://doaj.org/article/f25f244139b54e738782583da496136f
Autor:
Daniel D Degnan
Publikováno v:
Patient Safety, Vol 4, Iss SI (2022)
Fatal and nonfatal medication errors continue to occur in American healthcare. These are reported in a variety of ways and formats, and can include sensationalistic case reports about a patient receiving the wrong medication or more rigorous science-
Externí odkaz:
https://doaj.org/article/5f36ab5f6b124456bbc83cc80295a2ee
Autor:
Degnan DD; Regenstrief Center for Healthcare Engineering and Purdue University College of Pharmacy, West Lafayette, Indiana (Dr Degnan); University of Iowa Hospitals & Clinics, Iowa City, Iowa (Ms Bullard); University of Iowa Stead Family Children's Hospital (Ms Davis).; Daniel D. Degnan, PharmD, MS, CPPS, FASHP, is a clinical research associate at the Regenstrief Center for Healthcare Engineering and an associate director of the professional program laboratory at the Purdue University College of Pharmacy. Before working at Purdue, he spent 10 years as the medication safety officer at a health system in Indiana.; Tacia N. Bullard, MSN, RN, CNL, is a nursing practice leader in the Department of Nursing with Quality at the University of Iowa Hospitals & Clinics. She provides consultation, education, and evidenced-based knowledge to improve health outcomes with a focus on reducing health care-associated infections.; Mary Beth Hovda Davis, MSN, RN, VA-BC, is a nursing practice leader at the University of Iowa Stead Family Children's Hospital. She specializes in pediatric vascular access and provides consultation, education, and evidence-based quality improvement strategies and is interested in improving vascular access knowledge and implementation to better patient outcomes., Bullard TN; Regenstrief Center for Healthcare Engineering and Purdue University College of Pharmacy, West Lafayette, Indiana (Dr Degnan); University of Iowa Hospitals & Clinics, Iowa City, Iowa (Ms Bullard); University of Iowa Stead Family Children's Hospital (Ms Davis).; Daniel D. Degnan, PharmD, MS, CPPS, FASHP, is a clinical research associate at the Regenstrief Center for Healthcare Engineering and an associate director of the professional program laboratory at the Purdue University College of Pharmacy. Before working at Purdue, he spent 10 years as the medication safety officer at a health system in Indiana.; Tacia N. Bullard, MSN, RN, CNL, is a nursing practice leader in the Department of Nursing with Quality at the University of Iowa Hospitals & Clinics. She provides consultation, education, and evidenced-based knowledge to improve health outcomes with a focus on reducing health care-associated infections.; Mary Beth Hovda Davis, MSN, RN, VA-BC, is a nursing practice leader at the University of Iowa Stead Family Children's Hospital. She specializes in pediatric vascular access and provides consultation, education, and evidence-based quality improvement strategies and is interested in improving vascular access knowledge and implementation to better patient outcomes., Davis MBH; Regenstrief Center for Healthcare Engineering and Purdue University College of Pharmacy, West Lafayette, Indiana (Dr Degnan); University of Iowa Hospitals & Clinics, Iowa City, Iowa (Ms Bullard); University of Iowa Stead Family Children's Hospital (Ms Davis).; Daniel D. Degnan, PharmD, MS, CPPS, FASHP, is a clinical research associate at the Regenstrief Center for Healthcare Engineering and an associate director of the professional program laboratory at the Purdue University College of Pharmacy. Before working at Purdue, he spent 10 years as the medication safety officer at a health system in Indiana.; Tacia N. Bullard, MSN, RN, CNL, is a nursing practice leader in the Department of Nursing with Quality at the University of Iowa Hospitals & Clinics. She provides consultation, education, and evidenced-based knowledge to improve health outcomes with a focus on reducing health care-associated infections.; Mary Beth Hovda Davis, MSN, RN, VA-BC, is a nursing practice leader at the University of Iowa Stead Family Children's Hospital. She specializes in pediatric vascular access and provides consultation, education, and evidence-based quality improvement strategies and is interested in improving vascular access knowledge and implementation to better patient outcomes.
Publikováno v:
Journal of infusion nursing : the official publication of the Infusion Nurses Society [J Infus Nurs] 2020 May/Jun; Vol. 43 (3), pp. 146-154.
Autor:
Lenz JR; Eli Lilly and Company (Dr Lenz), Purdue University College of Pharmacy (Drs Degnan and Hertig), University of Michigan College of Pharmacy (Dr Stevenson), and Visante, Inc (Dr Stevenson). Janelle R. Lenz, PharmD, is internal liaison at Eli Lilly and Company, supporting field-based medical liaisons within the areas of neurodegeneration and pain. At the time of writing this article, Dr Lenz was completing a medication safety fellowship with the Purdue College of Pharmacy and Lilly. Daniel D. Degnan, PharmD, MS, CPPS, FASHP, is the senior project manager at the Center for Medication Safety Advancement at Purdue University College of Pharmacy. Previously, he spent 10 years as the medication safety officer at a large health system in Indiana. John B. Hertig, PharmD, MS, CPPS, is the associate director at the Center for Medication Safety Advancement at the Purdue University College of Pharmacy. He has professional interests in pharmacy practice health policy. He currently serves as a contributing editor for several quality and safety publications. James G. Stevenson, PharmD, FASHP, is a professor in the department of clinical pharmacy at the University of Michigan College of Pharmacy. He is also president of Visante, Inc, a medicines management consulting company. He served as chief pharmacy officer for the University of Michigan Health System for 15 years., Degnan DD, Hertig JB, Stevenson JG
Publikováno v:
Journal of infusion nursing : the official publication of the Infusion Nurses Society [J Infus Nurs] 2017 Nov/Dec; Vol. 40 (6), pp. 354-358.